GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (NSE:CAPLIPOINT) » Definitions » 10-Year Share Buyback Ratio

Caplin Point Laboratories (NSE:CAPLIPOINT) 10-Year Share Buyback Ratio : -0.10% (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Caplin Point Laboratories 10-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Caplin Point Laboratories's current 10-Year Share Buyback Ratio was -0.10%.

NSE:CAPLIPOINT's 10-Year Share Buyback Ratio is ranked better than
83.33% of 630 companies
in the Drug Manufacturers industry
Industry Median: -2.5 vs NSE:CAPLIPOINT: -0.10

Competitive Comparison of Caplin Point Laboratories's 10-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caplin Point Laboratories's 10-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's 10-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's 10-Year Share Buyback Ratio falls into.


;
;

Caplin Point Laboratories 10-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Caplin Point Laboratories (NSE:CAPLIPOINT) 10-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Caplin Point Laboratories 10-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's 10-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Caplin Point Laboratories Business Description

Traded in Other Exchanges
Address
Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.

Caplin Point Laboratories Headlines

No Headlines